FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jacob George

Research Profile

Disorders

Anatomy

Livers

Living Beings

Hepacivirus

Concepts & Ideas

Physiology

Genotype

Chemicals & Drugs

Procedures

Biopsy

Geographic Areas

Co-author Network

Publications

TOP 3
Roslyn Vongsuvanh; Jacob George; Liang Qiao; David van der Poorten
Visceral adiposity in gastrointestinal and hepatic carcinogenesis.
Farzan Fahrtash-Bahin; Jacob George; Timothy Gray; Viraj C Kariyawasam; Karen Byth; Mark W Douglas
Australian tertiary care outcomes of entecavir monotherapy in treatment naive patients with chronic hepatitis B.
David Booth; Jacob George
Loss of function of the new interferon IFN-λ4 may confer protection from hepatitis C.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jacob George (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Roslyn Vongsuvanh; Jacob George; Liang Qiao; David van der Poorten
Visceral adiposity in gastrointestinal and hepatic carcinogenesis.
Cancer letters 2013;330(1):1-10.
2013: Farzan Fahrtash-Bahin; Jacob George; Timothy Gray; Viraj C Kariyawasam; Karen Byth; Mark W Douglas
Australian tertiary care outcomes of entecavir monotherapy in treatment naive patients with chronic hepatitis B.
World journal of gastroenterology : WJG 2013;19(5):721-6.
2013: David Booth; Jacob George
Loss of function of the new interferon IFN-λ4 may confer protection from hepatitis C.
Nature genetics 2013;45(2):119-20.
2013: Monica Robotin; Yumi Patton; Jacob George
Getting it right: the impact of a continuing medical education program on hepatitis B knowledge of Australian primary care providers.
International journal of general medicine 2013;6():115-22.
2013: Janett Fischer; Jacob George; Christoph Sarrazin; Stephan Böhm; Thomas Berg
Impact of cohort size and host factors on combined analysis of interleukin 28B rs12979860 and rs8099917 in hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2013;57(1):416-7.
2012: Suzanne E Mahady; Germaine Wong; Jonathan C Craig; Jacob George
Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis.
Hepatology (Baltimore, Md.) 2012;56(6):2172-9.
2012: Jason Grebely; Margaret Hellard; John M Kaldor; Andrew R Lloyd; Gail V Matthews; Kathy Petoumenos; William Rawlinson; Barbara Yeung; Tanya Applegate; Gregory J Dore; Jordan J Feld; Jacob George
Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection.
AIDS (London, England) 2012;26(13):1653-61.
2012: Suzanne E Mahady; Jacob George
Management of nonalcoholic steatohepatitis: an evidence-based approach.
Clinics in liver disease 2012;16(3):631-45.
2012: Roslyn Vongsuvanh; Jacob George; Duncan McLeod; David van der Poorten
Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease.
Journal of hepatology 2012;57(2):392-8.
2012: Shelley E Keating; Jacob George; Daniel A Hackett; Nathan A Johnson
Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Journal of hepatology 2012;57(1):157-66.
2012: Vi Nguyen; Jacob George; David van der Poorten
A maxillary mass in a HBV-cirrhotic patient.
Liver international : official journal of the International Association for the Study of the Liver 2012;32(6):988.
2012: Heather F Gidding; Paul A W Haber; Matthew G Law; Graeme A Macdonald; George Ostapowicz; Joe J Sasadeusz; Martin Weltman; Janaki Amin; Jacob George; Gregory J Dore
Hepatitis C treatment outcomes in Australian clinics.
The Medical journal of Australia 2012;196(10):633-7.
2012: Janett Fischer; Balazs Fülöp; Jacob George; Pascal Migaud; Tobias Müller; Christoph Sarrazin; Markus Scholz; Eckart Schott; Graeme J Stewart; Vijayaprakash Suppiah; Simone Susser; Florian van Bommel; Heiko Witt; Stephan Böhm; David R Booth; Annika Brodzinski; Thomas Berg
Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection.
Hepatology (Baltimore, Md.) 2012;55(6):1700-10.
2012: Helen M Parker; Catriona A Burdon; Jeffrey S Cohn; Nathan A Johnson; Helen T O'Connor; Jacob George
Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Journal of hepatology 2012;56(4):944-51.
2012: Nathan A Johnson; Shelley E Keating; Jacob George
Exercise and the liver: implications for therapy in fatty liver disorders.
Seminars in liver disease 2012;32(1):65-79.
2012: Golo Ahlenstiel; David R Booth; Jacob George
Will IL28B polymorphisms remain relevant to direct-acting antiviral treatment paradigms?
Antiviral therapy 2012;17(6 Pt B):1163-70.
2011: Suzanne E Mahady; Arun Sanyal; Sarah Walker; Angela C Webster; Jacob George
The role of thiazolidinediones in non-alcoholic steatohepatitis - a systematic review and meta analysis.
Journal of hepatology 2011;55(6):1383-90.
2011: Leon A Adams; Elisabetta Bugianesi; Max Bulsara; Helena L I Ching; W Bastiaan De Boer; Jacob George; Enrico Rossi; David van der Poorten; Gary P Jeffrey
Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease.
Journal of gastroenterology and hepatology 2011;26(10):1536-43.
2011: neeraj bhala; Elisabetta Bugianesi; Phunchai Charatcharoenwitthaya; Christopher P Day; Jason M Hui; Eric Lee; Giorgio Saracco; Joanne H Topping; David van der Poorten; Leon A Adams; Paul Angulo; Jacob George
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.
Hepatology (Baltimore, Md.) 2011;54(4):1208-16.
2011: Vijayaprakash Suppiah; Martin Weltman; Maria Lorena Abate; Golo Ahlenstiel; Nicola J Armstrong; Margaret Bassendine; Thomas Berg; Pierre-Yves Bochud; David R Booth; Gregory J Dore; David Dunn; Silvana Gaudieri; Jacob George; Emma Hammond; Margaret Hellard; William L Irving; Simon Mallal; Gail Matthews; Tobias Müller; Jacob Nattermann; Francesco Negro; Kate S O'Connor; Elizabeth Powell; Stephen Riordan; David Anthony Sheridan; Antonina Smedile; Ulrich Spengler; Graeme J Stewart
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.
PLoS medicine 2011;8(9):e1001092.
2011: Gordon Jung-Hyuk Park; Francis Seow; Elke Wiseman; Caroline Fung; Jacob George; Peter H Katelaris; Meng Ngu
Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath test.
Journal of gastroenterology and hepatology 2011;26(9):1411-6.
2011: Scott R Walter; Hla-Hla Thein; Janaki Amin; Heather F Gidding; Kate Ward; Matthew G Law; Jacob George; Gregory J Dore
Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.
Journal of hepatology 2011;54(5):879-86.
2011: Venessa Pattullo; Mark W Douglas; Jacob George
Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis?
Expert review of gastroenterology & hepatology 2011;5(2):265-77.
2011: Katherine R Smith; Ulrich Spengler; Graeme J Stewart; Vijayaprakash Suppiah; Martin Weltman; Maria Lorena Abate; Golo Ahlenstiel; Melanie Bahlo; Margaret Bassendine; Thomas Berg; David R Booth; Jacob George; William L Irving; Gail Matthews; Kate O'Connor; Elizabeth Powell; Stephen Riordan
Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort.
Genome medicine 2011;3(8):57.
2011: Lionel Hebbard; Jacob George
Animal models of nonalcoholic fatty liver disease.
Nature reviews. Gastroenterology & hepatology 2011;8(1):35-44.
2010: Jason Grebely; Kathy Petoumenos; Margaret E Hellard; Gail V Matthews; Vijayaprakash Suppiah; Tanya Applegate; Barbara Yeung; Phillipa Marks; William D Rawlinson; Andrew R Lloyd; David Booth; John M Kaldor; Jacob George; Gregory J Dore
Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2010;52(4):1216-24.
2010: Golo Ahlenstiel; David R Booth; Jacob George
IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice.
Journal of gastroenterology 2010;45(9):903-10.
2010: Nathan A Johnson; Jacob George
Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.) 2010;52(1):370-81.
2010: Lionel Hebbard; Jacob George
The chicken or the egg: adipocytes and hepatic insulin resistance.
Hepatology (Baltimore, Md.) 2010;51(3):1076-9.
2010: Kerry-Lee Milner; David van der Poorten; Michael Trenell; Arthur B Jenkins; Aimin Xu; George Smythe; Gregory J Dore; Amany Zekry; Martin Weltman; Vincent Fragomeli; Jacob George; Donald J Chisholm
Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.
Gastroenterology 2010;138(3):932-41.e1-3.
2010: David van der Poorten; Mahsa Shahidi; Enoch Tay; Jayshree Sesha; Kayla Tran; Duncan McLeod; Jane S Milliken; Vikki Ho; Lionel W Hebbard; Mark W Douglas; Jacob George
Hepatitis C virus induces the cannabinoid receptor 1.
PloS one 2010;5(9):.
2010: Monica C Robotin; Melanie Q Kansil; Jacob George; Kirsten Howard; Steven Tipper; Miriam Levy; Nghi Phung; Andrew G Penman
Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilisation.
BMC health services research 2010;10():215.
2009: Vijayaprakash Suppiah; Max Moldovan; Golo Ahlenstiel; Thomas Berg; Martin Weltman; Maria Lorena Abate; Margaret Bassendine; Ulrich Spengler; Gregory J Dore; Elizabeth Powell; Stephen Riordan; David Anthony Sheridan; Antonina Smedile; Vincenzo Fragomeli; Tobias Müller; Melanie Bahlo; Graeme J Stewart; David R Booth; Jacob George
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.
Nature genetics 2009;41(10):1100-4.
2009: Nathan A Johnson; Toos Sachinwalla; David W Walton; Kate Smith; Ashley Armstrong; Martin W Thompson; Jacob George
Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.
Hepatology (Baltimore, Md.) 2009;50(4):1105-12.
2009: Mark W Douglas; Jacob George
Molecular mechanisms of insulin resistance in chronic hepatitis C.
World journal of gastroenterology : WJG 2009;15(35):4356-64.
2009: Nghi Phung; Natasha Pera; Geoffrey Farrell; Isabelle Leclercq; Jing Yun Hou; Jacob George
Pro-oxidant-mediated hepatic fibrosis and effects of antioxidant intervention in murine dietary steatohepatitis.
International journal of molecular medicine 2009;24(2):171-80.
2009: Jianhua Wang; Isabelle Leclercq; Joanne M Brymora; Ning Xu; Mehdi Ramezani-Moghadam; Roslyn M London; David Brigstock; Jacob George
Kupffer cells mediate leptin-induced liver fibrosis.
Gastroenterology 2009;137(2):713-23.
2009: Michael L Booth; Timothy Dobbins; Robert Aitken; Elizabeth Denney-Wilson; Louise L Hardy; Anthony D Okely; Jacob George; David Sullivan; Christopher T Cowell
Costs of managing conditions associated with obesity among Australian teenagers.
Journal of paediatrics and child health 2009;45(7-8):448-56.
2009: Alexis St George; Adrian Bauman; Amanda Johnston; Geoffrey Farrell; tien chey; Jacob George
Independent effects of physical activity in patients with nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.) 2009;50(1):68-76.
2009: Kerry-Lee Milner; David van der Poorten; Aimin Xu; Elisabetta Bugianesi; James G Kench; Karen S L Lam; Donald J Chisholm; Jacob George
Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.) 2009;49(6):1926-34.
2009: Alexis St George; Adrian Bauman; Amanda Johnston; Geoffrey Farrell; tien chey; Jacob George
Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
Journal of gastroenterology and hepatology 2009;24(3):399-407.
2009: Neeraj Bhala; Tim Usherwood; Jacob George
Non-alcoholic fatty liver disease.
BMJ (Clinical research ed.) 2009;339():b2474.
2008: Michael L Booth; Jacob George; Elizabeth Denney-Wilson; Anthony D Okely; Louise L Hardy; Robert Aitken; Timothy Dobbins
The population prevalence of adverse concentrations and associations with adiposity of liver tests among Australian adolescents.
Journal of paediatrics and child health 2008;44(12):686-91.
2008: David van der Poorten; Jacob George
Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis.
Clinics in liver disease 2008;12(4):805-24, ix.
2008: Jacob George; Elizabeth Denney-Wilson; Anthony D Okely; Louise L Hardy; Robert Aitken
The population distributions, upper normal limits and correlations between liver tests among Australian adolescents.
Journal of paediatrics and child health 2008;44(10):579-85.
2008: Ian Homer Y Cua; Jason M Hui; James G Kench; Jacob George
Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.
Hepatology (Baltimore, Md.) 2008;48(3):723-31.
2008: David van der Poorten; Kerry-Lee Milner; Jason Hui; Alexander Hodge; Michael I Trenell; James G Kench; Roslyn London; Tony Peduto; Donald J Chisholm; Jacob George
Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.
Hepatology (Baltimore, Md.) 2008;48(2):449-57.
2008: David van der Poorten; Dianna T Kenny; Jacob George
Prevalence of and risk factors for hepatitis C in Aboriginal and non-Aboriginal adolescent offenders.
The Medical journal of Australia 2008;188(10):610-4.
2008: Nathan A Johnson; David W Walton; Toos Sachinwalla; Campbell H Thompson; Kate Smith; Patricia A Ruell; Stephen R Stannard; Jacob George
Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders.
Hepatology (Baltimore, Md.) 2008;47(5):1513-23.
2008: Hossein Poustchi; Francesco Negro; Jason Hui; Ian Homer Y Cua; Laura Rubbia Brandt; James G Kench; Jacob George
Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.
Journal of hepatology 2008;48(1):28-34.
2007: David van der Poorten; Dianna T Kenny; Tony Butler; Jacob George
Liver disease in adolescents: A cohort study of high-risk individuals.
Hepatology (Baltimore, Md.) 2007;46(6):1750-8.
2007: David van der Poorten; Jacob George
Current and novel therapies for the treatment of nonalcoholic steatohepatitis.
Hepatology international 2007;1(3):343-54.
2007: Ian Homer Y Cua; Jason M Hui; Priyanka Bandara; James G Kench; Geoffrey C Farrell; Geoffrey W McCaughan; Jacob George
Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines.
Hepatology (Baltimore, Md.) 2007;46(1):66-73.
2007: Paul Angulo; Jason M Hui; Giulio Marchesini; Elisabetta Bugianesi; Jacob George; Geoffrey C Farrell; Felicity B Enders; Sushma Saksena; Alastair D Burt; John P Bida; Keith D Lindor; Schuyler O Sanderson; Marco Lenzi; Leon A Adams; James G Kench; Terry M Therneau; Christopher P Day
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.
Hepatology (Baltimore, Md.) 2007;45(4):846-54.
2006: Elisabetta Bugianesi; Giulio Marchesini; Elena Gentilcore; Ian Homer Y Cua; Ester Vanni; Mario Rizzetto; Jacob George
Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Hepatology (Baltimore, Md.) 2006;44(6):1648-55.
2006: Jian-Hua Wang; Robert-G Batey; Jacob George
Role of ethanol in the regulation of hepatic stellate cell function.
World journal of gastroenterology : WJG 2006;12(43):6926-32.
2006: Jacob George
Angiopoietin-like proteins: another player in the metabolic field.
Journal of hepatology 2006;44(4):832-4.
2005: Aileen dela Peña; Isabelle Leclercq; Jacqueline Field; Jacob George; Brett Jones; Geoffrey Farrell
NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis.
Gastroenterology 2005;129(5):1663-74.
2005: Leon A Adams; Max Bulsara; Enrico Rossi; Bastiaan DeBoer; David Speers; Jacob George; James G Kench; Geoffrey Farrell; Geoffrey W McCaughan; Gary P Jeffrey
Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.
Clinical chemistry 2005;51(10):1867-73.
2005: Dinesh Kumar; Geoffrey C Farrell; James G Kench; Jacob George
Hepatic steatosis and the risk of hepatocellular carcinoma in chronic hepatitis C.
Journal of gastroenterology and hepatology 2005;20(9):1395-400.
2005: Priyanka Bandara; Jacob George; Geoffrey W McCaughan; Daya Naidoo; Ora Lux; Chris Salonikas; James G Kench; Karen Byth; Geoffrey C Farrell
Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis C.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(3):518-26.
2005: Ian Homer Y Cua; Jacob George
Non-alcoholic fatty liver disease.
Hospital medicine (London, England : 1998) 2005;66(2):106-11.
2004: Jason M Hui; Alex Hodge; Geoffrey C Farrell; James G Kench; Adamandia D Kriketos; Jacob George
Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
Hepatology (Baltimore, Md.) 2004;40(1):46-54.
2004: Jason M Hui; Geoffrey C Farrell; James G Kench; Jacob George
High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD.
Hepatology (Baltimore, Md.) 2004;39(5):1458-9.
2004: Archana Sud; Jason M Hui; Geoffrey C Farrell; Priyanka Bandara; James G Kench; Caroline Fung; Rita Lin; Dev Samarasinghe; Christopher Liddle; Geoffrey W McCaughan; Jacob George
Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index.
Hepatology (Baltimore, Md.) 2004;39(5):1239-47.
2004: Shirley A Coverdale; Mahbub H Khan; Karen Byth; Rita Lin; Martin Weltman; Jacob George; Dev Samarasinghe; Christopher Liddle; James G Kench; Evelyn Crewe; Geoffrey C Farrell
Effects of interferon treatment response on liver complications of chronic hepatitis C: 9-year follow-up study.
The American journal of gastroenterology 2004;99(4):636-44.
2004: Shivakumar Chitturi; Geoffrey C Farrell; Jacob George
Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?
Journal of gastroenterology and hepatology 2004;19(4):368-74.
2003: Jason M Hui; Archana Sud; Geoffrey C Farrell; Priyanka Bandara; Karen Byth; James G Kench; Geoffrey W McCaughan; Jacob George
Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].
Gastroenterology 2003;125(6):1695-704.
2003: Jacob George; Natasha Pera; Nghi Phung; Isabelle Leclercq; Jing Yun Hou; Geoffrey Farrell
Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis.
Journal of hepatology 2003;39(5):756-64.
2003: Jason M Hui; James G Kench; Shivakumar Chitturi; Archana Sud; Geoffrey C Farrell; Karen Byth; Pauline Hall; Mahbub Khan; Jacob George
Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.
Hepatology (Baltimore, Md.) 2003;38(2):420-7.
2003: Shirley A Coverdale; Dev Samarasinghe; Rita Lin; James G Kench; Karen Byth; Mahbub H Khan; Evelyn Crewe; Christopher Liddle; Jacob George; Geoffrey C Farrell
Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progression.
The American journal of gastroenterology 2003;98(6):1384-90.
2003: David Lee; Shivakumar Chitturi; James G Kench; Jacob George; Steven Fuller; Kenneth F Bradstock; Rita Lin; Kai Ping Wong; Noel Young
Transjugular liver biopsy effecting changes in clinical management.
Australasian radiology 2003;47(2):117-20.
2003: Dinesh Kumar; Craig Wallington-Beddoe; Jacob George; Rita Lin; Dev Samarasinghe; Christopher Liddle; Geoffrey C Farrell
Effectiveness of interferon alfa-2b/ribavirin combination therapy for chronic hepatitis C in a clinic setting.
The Medical journal of Australia 2003;178(6):267-71.
2003: Shivakumar Chitturi; Jacob George
Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis.
Current gastroenterology reports 2003;5(1):18-25.
2002: Dinesh Kumar; Geoffrey C Farrell; Caroline Fung; Jacob George
Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response.
Hepatology (Baltimore, Md.) 2002;36(5):1266-72.
2002: Jason M Hui; James G Kench; Geoffrey C Farrell; Rita Lin; Dev Samarasinghe; Christopher Liddle; Karen Byth; Jacob George
Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.
Journal of gastroenterology and hepatology 2002;17(8):873-81.
2002: Shivakumar Chitturi; Geoffrey Farrell; Linda Frost; Adamandia D Kriketos; Rita Lin; Caroline Fung; Christopher Liddle; Dev Samarasinghe; Jacob George
Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?
Hepatology (Baltimore, Md.) 2002;36(2):403-9.
2002: Shivakumar Chitturi; Martin Weltman; Geoffrey C Farrell; David McDonald; James G Kench; Christopher Liddle; Dev Samarasinghe; Rita Lin; Shehan Abeygunasekera; Jacob George
HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
Hepatology (Baltimore, Md.) 2002;36(1):142-9.
2002: Shivakumar Chitturi; Vu Le; James G Kench; Christopher Loh; Jacob George
Gliclazide-induced acute hepatitis with hypersensitivity features.
Digestive diseases and sciences 2002;47(5):1107-10.
2002: Jason M Hui; Jacob George; Christopher Liddle; Rita Lin; Dev Samarasinghe; Evelyn Crewe; Geoffrey C Farrell
Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: effects of response and emergence of drug resistance.
The American journal of gastroenterology 2002;97(4):1003-9.
2002: Shivakumar Chitturi; Shehan Abeygunasekera; Geoffrey C Farrell; Jane Holmes-Walker; Jason M Hui; Caroline Fung; Rooshdiya Z Karim; Rita Lin; Dev Samarasinghe; Christopher Liddle; Martin Weltman; Jacob George
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.
Hepatology (Baltimore, Md.) 2002;35(2):373-9.
2002: Shivakumar Chitturi; Jacob George
Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs.
Seminars in liver disease 2002;22(2):169-83.
2000: Mahbub H Khan; Geoffrey C Farrell; Karen Byth; Rita Lin; Martin Weltman; Jacob George; Dev Samarasinghe; James G Kench; S Kaba; Evelyn Crewe; Christopher Liddle
Which patients with hepatitis C develop liver complications?
Hepatology (Baltimore, Md.) 2000;31(2):513-20.
1998: Mahbub H Khan; L Thomas; Karen Byth; James G Kench; Martin Weltman; Jacob George; Christopher Liddle; Geoffrey C Farrell
How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C?
Journal of gastroenterology and hepatology 1998;13(4):419-26.